Danaher | DHR - Assets



Danaher reported $81.62B in Assets for its fiscal quarter ending in June of 2025.


Assets Change Date
Abbott USD 84B 2.55B Jun/2025
Agilent USD 12.23B 68M Jul/2025
Align Technology USD 6.22B 116.27M Jun/2025
Becton, Dickinson and Co. USD 54.9B 435M Jun/2025
Bio Techne USD 2.56B 86.39M Jun/2025
Bio-Rad Laboratories USD 10.21B 687.2M Jun/2025
Boston Scientific USD 40.14B 745M Mar/2025
Bruker USD 6.34B 406.7M Jun/2025
Charles River Laboratories USD 7.56B 21.82M Jun/2025
Danaher USD 81.62B 2.5B Jun/2025
Dentsply International USD 6.07B 19M Jun/2025
Edwards Lifesciences USD 13.02B 33M Mar/2025
ESCO Technologies USD 2.53B 710.72M Jun/2025
Exact Sciences USD 5.8B 86.29M Jun/2025
Fortive USD 18.24B 1.11B Jun/2025
Henry Schein USD 10.91B 426M Jun/2025
Hologic USD 8.81B 261M Jun/2025
Illumina USD 6.09B 95M Jun/2025
Intuitive Surgical USD 20.16B 942.8M Jun/2025
IQVIA Holdings USD 28.63B 1.31B Jun/2025
Keysight Technologies USD 10.65B 102M Jul/2025
Laboratory Of America USD 18.06B 456.1M Jun/2025
Medtronic USD 91.68B 1.71B Apr/2025
Mettler Toledo International USD 3.4B 165.79M Jun/2025
Myriad Genetics USD 1.01B 21.5M Mar/2025
Quest Diagnostics USD 15.97B 172M Jun/2025
Quidel USD 6.38B 82.5M Jun/2025
Repligen USD 2.85B 22.48M Mar/2025
Revvity USD 12.36B 2.06M Jun/2025
Roper Industries USD 33.22B 1.8B Jun/2025
Stryker USD 46.33B 325M Jun/2025
Thermo Fisher Scientific USD 101.23B 2.19B Jun/2025
Waters USD 4.72B 126.5M Jun/2025
Zimmer Biomet Holdings USD 22.87B 681.2M Jun/2025